Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Recent News

View:

Post by SkywalkerofLuke on Jan 16, 2023 5:03pm

Recent News

After completing the Phase 2a study of Ifenprodil and seeing significant positive results, AGN.c AGNPF announced last week a 180 patient, 90-day Phase 2b clinical study of Ifenprodil for chronic cough to begin in Q3.

As Jacky Smith, Professor of Respiratory Medicine at the University of Manchester, stated, “I am very pleased Algernon has decided to conduct a stand-alone, Phase 2b study for cough . . . based on Algernon’s encouraging Phase 2a clinical data.”

The chronic cough market is expected to reach $11.38B by 2029 and with AGN planning to file an investigational new drug application with the FDA shortly, I’m watching AGN.

https://www.youtube.com/watch?v=REtP6b3LwY0

167